No Data
GRAND PHARMA To Go Ex-Dividend On June 12th, 2026 With 0.169 HKD Dividend Per Share
June 11th (Beijing Time) - $GRAND PHARMA(00512.HK)$ is trading ex-dividend on June 12th, 2026.Shareholders of record on June 15th, 2026 will receive 0.169 HKD dividend per share on June 30th, 2026.
Grand Pharmaceutical Formalizes Huadong Medicine Supply Deal as Continuing Connected Transaction
Grand Pharmaceutical (00512.HK) Radiopharmaceutical Partner Showcases Breakthrough Product at ASCO; First-in-Class RDC Drug Demonstrates Robust Data, Reinforcing Global Competitiveness
Recently, Telix Pharmaceuticals Limited, a key strategic partner of Grand Pharmaceutical Group Limited (HKEX: 00512) in the radiopharmaceuticals sector, showcased its global innovative product TLX591-Tx prominently at the 2026 ASCO Annual Meeting.
Express News | A pharmacy in Hohhot, Inner Mongolia, sold centrally procured medicine at inflated prices; local authorities summoned its principal for a meeting.
Express News | Ministry of Commerce Holds Roundtable Meeting with Foreign-Invested Enterprises in the Pharmaceutical Industry
Grand Pharmaceutical (0512.HK): The impact of centralized procurement has been phased out, and its self-developed nuclear medicine has entered the clinical stage.
Matter: The company released its 2025 annual report, achieving revenue of HKD 12.283 billion, representing a year-on-year increase of 5.45%; the profit attributable to the company's shareholders was HKD 1.241 billion, marking a year-on-year decrease of 49.73%; excluding